Your SlideShare is downloading. ×
Pioglitazone is Back
Pioglitazone is Back
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Pioglitazone is Back

629

Published on

The Union Ministry of Health and Family Welfare on Wednesday endorsed the recommendation of the Drugs Technical Advisory Board (DTAB) to revoke the ban on pioglitazone — an oral anti-diabetic drug …

The Union Ministry of Health and Family Welfare on Wednesday endorsed the recommendation of the Drugs Technical Advisory Board (DTAB) to revoke the ban on pioglitazone — an oral anti-diabetic drug which was banned on June 18. The drug will now be sold with a box warning (that the drug carries a significant risk of serious or even life-threatening adverse effects) and will also carry an inset. Doctors will also be told that pioglitazone should not be prescribed as the first line of treatment.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
629
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

×